Symrise AG Unsponsored ADR (OTCMKTS:SYIEY – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the seven research firms that are covering the stock, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company.
SYIEY has been the subject of a number of analyst reports. Morgan Stanley reiterated an “overweight” rating on shares of Symrise in a research report on Thursday, August 27th. Jefferies Financial Group raised Symrise from a “hold” rating to a “buy” rating in a research report on Tuesday, September 1st. The Goldman Sachs Group cut Symrise from a “buy” rating to a “neutral” rating in a report on Monday, June 8th. Sanford C. Bernstein upgraded Symrise to a “hold” rating in a research report on Wednesday, July 22nd. Finally, Citigroup reissued a “buy” rating on shares of Symrise in a report on Friday, September 25th.
View Our Latest Analysis on Symrise
Symrise Trading Down 1.8%
Symrise Company Profile
Symrise AG is a Germany-based global supplier of flavorings, fragrances, cosmetic ingredients and nutritional solutions. The company develops ingredients and formulation systems used by manufacturers in the food and beverage, consumer goods, fragrance, personal care and health industries.
Its business is organized around areas that include Taste, Scent and Care, and Nutrition. Products and services include flavors for foods and beverages, fragrance compounds for perfumes and household products, functional ingredients for cosmetics and personal care, and ingredients used in dietary supplements, pet food and other nutrition applications.
Symrise was formed in 2003 through the merger of Haarmann & Reimer and Dragoco, two businesses with roots in the European flavor and fragrance industry.
Featured Stories
- Five stocks we like better than Symrise
- Everyone in AI Is Quietly Copying Palantir’s Playbook
- Advanced Micro Devices Is Spending $8.2 Billion to Learn What AI Needs Next
- JPMorgan Bets on Genius Sports as the Market Loses Patience
- Appleās $5.7 Billion Patent Verdict Raises a Bigger Royalty Question
Receive News & Ratings for Symrise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Symrise and related companies with MarketBeat.com's FREE daily email newsletter.
